DAA112 |
inositol 1,4,5-trisphosphate 3-kinase A |
Molecular |
brain |
Human |
ITPKA |
24.0% Decrease Gene Expression Level |
|
DAA113 |
inositol 1,4,5-trisphosphate 3-kinase B |
Molecular |
brain |
Human |
ITPKB |
15.0% Increase Gene Expression Level |
|
DAA109 |
insulin receptor |
Molecular |
brain |
Human |
INSR |
8.0% Increase Gene Expression Level |
|
DAA111 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
Molecular |
brain |
Human |
ITGB1 |
7.0% Increase Gene Expression Level |
|
DAA101 |
holocytochrome c synthase (cytochrome c heme-lyase) |
Molecular |
brain |
Human |
HCCS |
14.0% Decrease Gene Expression Level |
|
DAA133 |
microtubule-associated protein tau |
Molecular |
brain |
Human |
MAPT |
14.0% Decrease Gene Expression Level |
|
DAA110 |
iron-responsive element binding protein 2 |
Molecular |
brain |
Human |
IREB2 |
25.0% Decrease Gene Expression Level |
|
DAA117 |
kinesin family member 3C |
Molecular |
brain |
Human |
KIF3C |
9.0% Decrease Gene Expression Level |
|
DAA10 |
KN motif and ankyrin repeat domains 1 |
Molecular |
brain |
Human |
KANK1 |
16.0% Increase Gene Expression Level |
|
DAA614 |
Parkinson's disease |
Pathological |
central nervous system |
Human |
— |
SeriesMorbidity |
|
DAA606 |
Cancer of meninges, brain and other parts of central nervous system |
Pathological |
central nervous system |
Human |
— |
SeriesMorbidity |
|
DAA715 |
Lipid biosynthesis decreases |
Physiological |
central nervous system |
Human |
— |
— |
|
DAA757 |
Parkinsonian signs |
Physiological |
nervous system |
Human |
— |
— |
|
DAA742 |
Motor function impairment evident in altered gait and balance |
Physiological |
nervous system |
Human |
— |
— |
|
DAA1983 |
Critical decline in fine motor hand movements |
Physiological |
nervous system |
Human |
— |
— |
|